| Followers | 22 |
| Posts | 2381 |
| Boards Moderated | 1 |
| Alias Born | 09/27/2020 |
Sunday, March 15, 2026 2:37:36 AM
Everyone knows a CIC vaccine is the next major step for several top vaccine makers. We know the Novavax CIC has indicated strong positive results in testing done so far, and we expect a major play to step forward at some point to advance our CIC asset. Some have speculated that the reduced discussions of our CIC asset is likely the result of ongoing negotiations with one or more major players, and the company won't discuss CIC much going forward until a deal is inked. I agree with that assessment over those claiming our CIC has no interest and is going nowhere.
I fully expect we will see news this week or next week that moves share price significantly higher. Sanofi deal >>> Pfizer deal >>> who is next??? The time between deals will accelerate, shorts will move on to easier targets, the convertible debt will be retired when additional up-front cash is received... I mean, how far does the company need to extend operational funding given the current cash position and continuing reductions in O&M planned? It would seem pointless to extend operational funding to end of 2029 with this convertible debt still creating negative share price appreciation through hedge fund arbitrage trading. When this debt is gone and shorts have moved on, there will be nothing remaining that keeps share price from moving toward true value, which we all know is much higher than current share price.
Recent NVAX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 10:13:36 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/09/2026 10:12:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:04:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:03:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:02:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:01:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:00:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:37:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:35:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:34:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:33:22 AM
- Novavax to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/26/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:02:10 PM
- Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights • PR Newswire (US) • 02/26/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 12:33:51 PM
- Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 • PR Newswire (US) • 02/19/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 12:57:59 AM
- Novavax shares gain after Matrix-M adjuvant licensing deal with Pfizer • IH Market News • 01/20/2026 02:48:06 PM
- Novavax Announces Entering into a License Agreement with Pfizer • PR Newswire (US) • 01/20/2026 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 11:59:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:01:06 PM
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
